Ingran Lingam1, Adnan Avdic-Belltheus1, Christopher Meehan1, Kathryn Martinello1,2, Sara Ragab1, Donald Peebles3, Melinda Barkhuizen4, Cally J Tann1,5, Ilias Tachtsidis6, Tim G A M Wolfs4, Henrik Hagberg7, Nigel Klein8, Bobbi Fleiss9, Pierre Gressens9,10, Xavier Golay11, Boris W Kramer3, Nicola J Robertson12. 1. Neonatology, Institute for Women's Health, University College London, London, UK. 2. Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia. 3. Maternal Fetal Medicine, Institute for Women's Health, University College London, London, UK. 4. Department of Pediatrics, University of Maastricht, Maastricht, The Netherlands. 5. Maternal Adolescent, Reproductive and Child Health (MARCH) Centre, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK. 6. Medical Physics and Biomedical Engineering, University College London, London, UK. 7. Centre of Perinatal Medicine & Health, Department of Clinical Sciences, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden. 8. Paediatric Infectious Diseases & Immunology, Institute of Child Health, University College London, London, UK. 9. Centre for the Developing Brain, Kings College London, London, UK. 10. PROTECT, INSERM, Université Paris Diderot, Sorbonne Paris Cité, 75019, Paris, France. 11. Department of Brain Repair & Rehabilitation, Institute of Neurology, University College London, London, UK. 12. Neonatology, Institute for Women's Health, University College London, London, UK. n.robertson@ucl.ac.uk.
Abstract
BACKGROUND: Exposure to inflammation exacerbates injury in neonatal encephalopathy (NE). We hypothesized that brain biomarker mRNA, cytokine mRNA and microRNA differentiate inflammation (E. coli LPS), hypoxia (Hypoxia), and inflammation-sensitized hypoxia (LPS+Hypoxia) in an NE piglet model. METHODS: Sixteen piglets were randomized: (i) LPS 2 μg/kg bolus; 1 μg/kg infusion (LPS; n = 5), (ii) Saline with hypoxia (Hypoxia; n = 6), (iii) LPS commencing 4 h pre-hypoxia (LPS+Hypoxia; n = 5). Total RNA was acquired at baseline, 4 h after LPS and 1, 3, 6, 12, 24, 48 h post-insult (animals euthanized at 48 h). Quantitative PCR was performed for cytokines (IL1A, IL6, CXCL8, IL10, TNFA) and brain biomarkers (ENO2, UCHL1, S100B, GFAP, CRP, BDNF, MAPT). MicroRNA was detected using GeneChip (Affymetrix) microarrays. Fold changes from baseline were compared between groups and correlated with cell death (TUNEL) at 48 h. RESULTS: Within 6 h post-insult, we observed increased IL1A, CXCL8, CCL2 and ENO2 mRNA in LPS+Hypoxia and LPS compared to Hypoxia. IL10 mRNA differentiated all groups. Four microRNAs differentiated LPS+Hypoxia and Hypoxia: hsa-miR-23a, 27a, 31-5p, 193-5p. Cell death correlated with TNFA (R = 0.69; p < 0.01) at 1-3 h and ENO2 (R = -0.69; p = 0.01) at 48 h. CONCLUSIONS: mRNA and miRNA differentiated hypoxia from inflammation-sensitized hypoxia within 6 h in a piglet model. This information may inform human studies to enable triage for tailored neuroprotection in NE. IMPACT: Early stratification of infants with neonatal encephalopathy is key to providing tailored neuroprotection. IL1A, CXCL8, IL10, CCL2 and NSE mRNA are promising biomarkers of inflammation-sensitized hypoxia. IL10 mRNA levels differentiated all three pathological states; fold changes from baseline was the highest in LPS+Hypoxia animals, followed by LPS and Hypoxia at 6 h. miR-23, -27, -31-5p and -193-5p were significantly upregulated within 6 h of a hypoxia insult. Functional analysis highlighted the diverse roles of miRNA in cellular processes.
BACKGROUND: Exposure to inflammation exacerbates injury in neonatal encephalopathy (NE). We hypothesized that brain biomarker mRNA, cytokine mRNA and microRNA differentiate inflammation (E. coli LPS), hypoxia (Hypoxia), and inflammation-sensitized hypoxia (LPS+Hypoxia) in an NE piglet model. METHODS: Sixteen piglets were randomized: (i) LPS 2 μg/kg bolus; 1 μg/kg infusion (LPS; n = 5), (ii) Saline with hypoxia (Hypoxia; n = 6), (iii) LPS commencing 4 h pre-hypoxia (LPS+Hypoxia; n = 5). Total RNA was acquired at baseline, 4 h after LPS and 1, 3, 6, 12, 24, 48 h post-insult (animals euthanized at 48 h). Quantitative PCR was performed for cytokines (IL1A, IL6, CXCL8, IL10, TNFA) and brain biomarkers (ENO2, UCHL1, S100B, GFAP, CRP, BDNF, MAPT). MicroRNA was detected using GeneChip (Affymetrix) microarrays. Fold changes from baseline were compared between groups and correlated with cell death (TUNEL) at 48 h. RESULTS: Within 6 h post-insult, we observed increased IL1A, CXCL8, CCL2 and ENO2 mRNA in LPS+Hypoxia and LPS compared to Hypoxia. IL10 mRNA differentiated all groups. Four microRNAs differentiated LPS+Hypoxia and Hypoxia: hsa-miR-23a, 27a, 31-5p, 193-5p. Cell death correlated with TNFA (R = 0.69; p < 0.01) at 1-3 h and ENO2 (R = -0.69; p = 0.01) at 48 h. CONCLUSIONS: mRNA and miRNA differentiated hypoxia from inflammation-sensitized hypoxia within 6 h in a piglet model. This information may inform human studies to enable triage for tailored neuroprotection in NE. IMPACT: Early stratification of infants with neonatal encephalopathy is key to providing tailored neuroprotection. IL1A, CXCL8, IL10, CCL2 and NSE mRNA are promising biomarkers of inflammation-sensitized hypoxia. IL10 mRNA levels differentiated all three pathological states; fold changes from baseline was the highest in LPS+Hypoxia animals, followed by LPS and Hypoxia at 6 h. miR-23, -27, -31-5p and -193-5p were significantly upregulated within 6 h of a hypoxia insult. Functional analysis highlighted the diverse roles of miRNA in cellular processes.
Authors: S Eklind; C Mallard; A L Leverin; E Gilland; K Blomgren; I Mattsby-Baltzer; H Hagberg Journal: Eur J Neurosci Date: 2001-03 Impact factor: 3.386
Authors: Frank P Zemlan; Edward C Jauch; J Jeffery Mulchahey; S Prasad Gabbita; William S Rosenberg; Samuel G Speciale; Mario Zuccarello Journal: Brain Res Date: 2002-08-23 Impact factor: 3.252
Authors: Dorothea D Jenkins; Timothy Lee; Cody Chiuzan; Jessica K Perkel; Laura Grace Rollins; Carol L Wagner; Lakshmi P Katikaneni; W Thomas Bass; David A Kaufman; Michael J Horgan; Sheela Laungani; Laurence M Givelichian; Koravangatta Sankaran; Jerome Y Yager; Renee Martin Journal: Pediatr Crit Care Med Date: 2013-10 Impact factor: 3.624
Authors: Anne C C Lee; Naoko Kozuki; Hannah Blencowe; Theo Vos; Adil Bahalim; Gary L Darmstadt; Susan Niermeyer; Matthew Ellis; Nicola J Robertson; Simon Cousens; Joy E Lawn Journal: Pediatr Res Date: 2013-12 Impact factor: 3.756
Authors: Cally J Tann; Margaret Nakakeeto; Barbara A Willey; Margaret Sewegaba; Emily L Webb; Ibby Oke; Emmanuel Derek Mutuuza; Donald Peebles; Margaret Musoke; Kathryn A Harris; Neil J Sebire; Nigel Klein; Jennifer J Kurinczuk; Alison M Elliott; Nicola J Robertson Journal: Arch Dis Child Fetal Neonatal Ed Date: 2017-08-05 Impact factor: 5.747
Authors: Sharmony B Kelly; Vanesa Stojanovska; Valerie A Zahra; Alison Moxham; Suzanne L Miller; Timothy J M Moss; Stuart B Hooper; Marcel F Nold; Claudia A Nold-Petry; Justin M Dean; Laura Bennet; Graeme R Polglase; Alistair J Gunn; Robert Galinsky Journal: J Neuroinflammation Date: 2021-08-31 Impact factor: 8.322
Authors: Maria E Bernis; Yvonne Schleehuber; Margit Zweyer; Elke Maes; Ursula Felderhoff-Müser; Daniel Picard; Hemmen Sabir Journal: Oxid Med Cell Longev Date: 2022-03-02 Impact factor: 6.543